H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Census population 123,851. Michigan Medicare wound biologics: WPS Government Health Administrators (J8). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Ann Arbor clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Ann Arbor storefront.
Biodynamic Hematogel Wound Care in Ann Arbor, MI for clinics & physicians. Biodynamic hematogel achieves 9… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Obesity 25.8%; arthritis 16.7%. Those three PLACES crude rates (plus Census 123,851) are the local facts on this page. Everything else is the national biodynamic hematogel catalog and J8 paperwork.
National Biodynamic Hematogel Wound Care notes (how the product actually works)Three grains, kept separate on purpose. City: Census 123,851 and CDC PLACES crude rates. State: Michigan Department of Health & Human Services, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and WPS Government Health Administrators LCDs. CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Ann Arbor trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 6.4% of adults — 5.6 points below the U.S. 12% figure. Obesity is 25.8%; arthritis is 16.7%. That is place-level BRFSS modeling, not a clinic census and not a Ann Arbor trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Michigan.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers biodynamic hematogel wound care and which products they use.
Michigan is J8. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
Bring specialty, monthly wound volume, and whether you bill J8 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 6.4% diabetes and 16.7% arthritis for Ann Arbor — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Ann Arbor, MI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Ann Arbor is J8 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Ann Arbor — 5.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Michigan Part B wound biologics follow this contractor (siblings: IN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Ann Arbor. Useful for joint-program math; still needs a diagnosis and privileging.
No Ann Arbor storefront. Joe Bradley is an active practice owner. biodynamic hematogel stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.